Published in AIDS on September 28, 2001
Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol (2008) 2.48
Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs. J Infect Dis (2003) 1.33
Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection. Proc Natl Acad Sci U S A (2002) 1.12
Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure. AIDS Res Hum Retroviruses (2006) 1.03
CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology (2003) 1.01
Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment. Curr Infect Dis Rep (2003) 0.96
Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol (2003) 0.93
Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus. J Virol (2002) 0.91
A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy. Clin Exp Immunol (2003) 0.83
Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy. J Allergy Clin Immunol (2006) 0.80
Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation. Clin Exp Immunol (2007) 0.79
What limits immune reconstitution in HIV infection? Divergent tools converge on thymic function. AIDS (2001) 0.76
Reconstitution of Peripheral T Cells by Tissue-Derived CCR4+ Central Memory Cells Following HIV-1 Antiretroviral Therapy. Pathog Immun (2016) 0.75
Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis (1998) 3.69
A potential role for interleukin-7 in T-cell homeostasis. Blood (2001) 3.56
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis (1996) 2.49
Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol (1998) 2.38
Mechanisms of HIV-associated lymphocyte apoptosis. Blood (2000) 1.75
Degenerative lumbar spondylolisthesis. A meta-analysis of literature 1970-1993. Spine (Phila Pa 1976) (1994) 1.75
Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol (2008) 1.70
Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS (1998) 1.69
Defense factors of vaginal lactobacilli. Am J Obstet Gynecol (2001) 1.68
Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA (1998) 1.68
Hydroxyapatite augmentation of the porous coating improves fixation of tibial components. A randomised RSA study in 116 patients. J Bone Joint Surg Br (1998) 1.66
Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. J Immunol (1983) 1.65
HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care (2002) 1.63
Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings. Ann Intern Med (1983) 1.51
NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med (1992) 1.50
Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord (1995) 1.49
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS (2001) 1.45
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis (2000) 1.43
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS (2000) 1.41
Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol (1998) 1.41
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS (1999) 1.40
Anion gap determination in preeclampsia. Obstet Gynecol (1998) 1.39
American Society of Pediatric Otolaryngology news. Arch Otolaryngol Head Neck Surg (1994) 1.38
In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest (1998) 1.36
Effects of pudendal nerve injury in the female rat. Neurourol Urodyn (2000) 1.36
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points. J Infect Dis (1999) 1.30
Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet Gynecol (1997) 1.27
Repair of full thickness rotator cuff tears. Gender, age, and other factors affecting outcome. Clin Orthop Relat Res (1999) 1.24
Outcome after rectovaginal fascia reattachment for rectocele repair. Am J Obstet Gynecol (1999) 1.19
Current trends in the management of adamantinoma of long bones. An international study. J Bone Joint Surg Am (2000) 1.18
Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells. Immunology (2001) 1.18
An approach to the validation of markers for use in AIDS clinical trials. Clin Infect Dis (1997) 1.17
Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr (1999) 1.15
Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome. JAMA (1987) 1.14
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis (2000) 1.13
Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum (1999) 1.13
The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res (2000) 1.12
Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol (1994) 1.11
Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS (2001) 1.11
Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol (1997) 1.09
Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. Am J Pathol (2000) 1.09
The analgesic effects of subhypnotic doses of propofol in human volunteers with experimentally induced tourniquet pain. AANA J (2001) 1.08
Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA). J Immunol Methods (2000) 1.08
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS (2000) 1.07
Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage (1996) 1.07
Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells. J Clin Immunol (1984) 1.05
Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage (2000) 1.05
The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol (1999) 1.04
Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.02
Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest (2001) 1.01
Accuracy and precision of radiostereometric analysis in the measurement of THR femoral component translations: human and canine in vitro models. J Orthop Res (2001) 1.01
Results of the flow cytometry ACTG quality control program: analysis and findings. Clin Immunol Immunopathol (1989) 1.01
Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin Immunol (1999) 1.01
Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol (1998) 1.01
HIV isolation from plasma of HIV-infected persons. N Engl J Med (1987) 1.00
Isotype switching in human B lymphocyte malignancies occurs by DNA deletion: evidence for nonspecific switch recombination. J Immunol (1987) 1.00
Barriers to cancer pain relief: fear of tolerance and addiction. J Pain Symptom Manage (1998) 1.00
Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates. J Clin Microbiol (1998) 1.00
A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS (1997) 0.99
A comparison of women with primary and recurrent pelvic prolapse. Am J Obstet Gynecol (1999) 0.97
Effect of preoperative voiding mechanism on success rate of autologous rectus fascia suburethral sling procedure. Obstet Gynecol (1998) 0.97
Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol (1990) 0.97
Immunological effects of antiretroviral and immune therapies for HIV. AIDS (1997) 0.94
Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Med (2004) 0.94
Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes. Clin Immunol (2000) 0.93
A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry. Clin Immunol Immunopathol (1994) 0.93
Enumeration of human lymphocyte subpopulations by immunofluorescence: a comparative study using automated flow microfluorometry and fluorescence microscopy. J Immunol Methods (1983) 0.93
Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility. Am J Obstet Gynecol (2001) 0.92
Monocyte functional studies in asymptomatic, human immunodeficiency disease virus (HIV)-infected individuals. J Clin Immunol (1988) 0.92
Responsiveness of quality of life measurements to change after reconstructive pelvic surgery. Am J Obstet Gynecol (2001) 0.92
The anatomic and functional variability of rectoceles in women. Int Urogynecol J Pelvic Floor Dysfunct (1999) 0.92
Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum (1996) 0.91
Predicting the risk of pressure ulcers in critically ill patients. Am J Crit Care (1999) 0.91
Contributions of bone density and geometry to the strength of the human second metatarsal. Bone (2000) 0.90
Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics. J Infect Dis (2001) 0.90
The radiographic joint space width in clinically normal hips: effects of age, gender and physical parameters. Osteoarthritis Cartilage (2003) 0.90
In vivo measurement of the subchondral bone thickness of lumbar facet joint using magnetic resonance imaging. Osteoarthritis Cartilage (2010) 0.90
Occipitocervical stabilization for myelopathy in patients with rheumatoid arthritis. Implications of not bone-grafting. J Bone Joint Surg Am (2000) 0.89
The inhibitory effect of clindamycin on Lactobacillus in vitro. Infect Dis Obstet Gynecol (2001) 0.89
A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis (1998) 0.88
Bupivacaine for postoperative pain relief at the iliac crest bone graft harvest site. Am J Orthop (Belle Mead NJ) (2000) 0.87
Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor. J Infect Dis (1997) 0.87
Gamma/delta T cell receptor positive T cells in the inflammatory joint: lack of association with response to soluble antigens. Cell Immunol (1991) 0.87
Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation. Lancet (1999) 0.87
HIV in the female genital tract: viral shedding and mucosal immunity. Clin Obstet Gynecol (2001) 0.86
Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs (1998) 0.86
Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2001) 0.86
Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect Dis Obstet Gynecol (2001) 0.86
Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection. Clin Immunol Immunopathol (1997) 0.86
Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs. Science (1983) 0.85
Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 0.85
Bacterial contamination of blenderized whole food and commercial enteral tube feedings in the Philippines. J Hosp Infect (2001) 0.84